GridAI Technologies (GRDX) Other Accumulated Expenses (2019 - 2025)
GridAI Technologies' (GRDX) quarterly Other Accumulated Expenses came in at $14870.0 in Q4 2025, up 1103.07% YoY from $1236.0 in Q4 2024, and down 75.0% on a QoQ basis from $59482.0 in Q3 2025.
GridAI Technologies (GRDX) Other Accumulated Expenses (2019 - 2025) Analysis & Trends
GridAI Technologies (GRDX) has 7 years of Other Accumulated Expenses data on file, last reported at $14870.0 in Q4 2025.
- Quarterly Other Accumulated Expenses rose 1103.07% year-over-year to $14870.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $14870.0 (up 1103.07% YoY) and the FY2025 annual result came in at $14870.0, up 1103.07% from the prior year.
- Other Accumulated Expenses slipped to $14870.0 in Q4 2025, from $59482.0 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $189625.0 in Q2 2021 to a low of $1236.0 in Q4 2024.
- A 5-year average of $47521.1 and a median of $14870.0 in 2025 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2022 — Other Accumulated Expenses slumped 93.41% — and 2025, when it soared 1103.07%.
- Tracing GRDX's Other Accumulated Expenses over 5 years: stood at $14818.0 in 2021, then dropped by 18.09% to $12138.0 in 2022, then plunged by 65.08% to $4239.0 in 2023, then tumbled by 70.84% to $1236.0 in 2024, then soared by 1103.07% to $14870.0 in 2025.
- The last three Other Accumulated Expenses figures came in at $14870.0 (Q4 2025), $59482.0 (Q3 2025), and $105918.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | GridAI Technologies | 5.82 Mn | 5.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14,870.00 |
| Sep 30, 2025 | 59,482.00 |
| Jun 30, 2025 | 105,918.00 |
| Mar 31, 2025 | 135,659.00 |
| Dec 31, 2024 | 1,236.00 |
| Jun 30, 2024 | 8,974.00 |
| Mar 31, 2024 | 28,546.00 |
| Dec 31, 2023 | 4,239.00 |
| Sep 30, 2023 | 10,806.00 |
| Jun 30, 2023 | 29,907.00 |
| Mar 31, 2023 | 12,123.00 |
| Dec 31, 2022 | 12,138.00 |
| Sep 30, 2022 | 10,951.00 |
| Jun 30, 2022 | 13,408.00 |
| Mar 31, 2022 | 18,575.00 |
| Dec 31, 2021 | 14,818.00 |
| Sep 30, 2021 | 166,291.00 |
| Jun 30, 2021 | 189,625.00 |
| Mar 31, 2021 | 65,335.00 |
| Dec 31, 2020 | 57,417.00 |